Myth or evidence? · Episode 1
Short answer: There is no evidence that myrcene in a cannabis flower reliably makes people tired or improves their sleep. The frequently cited experiment investigated whether myrcene prolonged a state induced in mice by the sleeping medication pentobarbital. One human study tested a capsule containing CBD and eight terpenes, including myrcene. It cannot determine the effect of myrcene alone.
What exactly does “myrcene makes you tired” claim?
Myrcene is a volatile plant compound with an earthy, sometimes hop-like aroma. It occurs in hops and in some cannabis samples, among other things. A laboratory can measure its proportion in a specific sample. However, this does not yet test whether a person becomes tired after consumption.
The phrase “makes you tired” conflates several possible endpoints: acute daytime drowsiness, time taken to fall asleep, total sleep time, proportion of deep sleep and subjectively restorative sleep. A substance can change one of these measures without improving the others. For the word “reliably” to apply, an effect would need to have been demonstrated repeatedly in many people under comparable conditions. According to the literature evaluated here, no such evidence exists for isolated myrcene in the amounts typically found in cannabis flower.
The exposure must also be appropriate. A pure substance injected into a mouse’s abdominal cavity, an oral capsule containing CBD and several terpenes, and the aerosol from heated flower are different experiments. Their results are not interchangeable.
Which study established its reputation as a sleep terpene?
The 2002 paper by do Vale and colleagues is frequently cited. They investigated citral, myrcene and limonene in male Swiss mice. The isolated substances were injected into the abdominal cavity. Neither a combination with THC nor cannabis flower was involved. They assessed movement, performance on a rotating rod, behaviour in an elevated plus maze and the duration of a sleep state induced by pentobarbital.
A longer pentobarbital test result can have several causes. Initially, it shows that the experimental conditions affected the duration of the drug-induced state. It measures neither the time taken to fall asleep without medication nor sleep quality in humans. Reduced movement in an open field is likewise not equivalent to better sleep: fatigue, motor impairment and other causes would need to be distinguished.
The full text also contains discrepancies between individual results tables and the presentation in the main text. In Table 1, the reduction in field crossings at 100 mg/kg is marked as significant, whereas the reduction at 200 mg/kg is not. This does not support a simple rule that “more myrcene equals more sedation”. The detailed assessment of the original paper is already available in our terpene overview.
Why is pentobarbital-induced sleep not normal sleep?
Pentobarbital is a medicinal substance that makes the experimental design possible in the first place. Such tests often measure the time between the loss and return of the righting reflex. This is a pharmacological endpoint. It does not answer whether an animal falls asleep sooner without the substance, sleeps longer or feels more rested the following day.
An older rat study also illustrates the problem: Freitas and colleagues investigated myrcene and pentobarbital using a different route of administration. After a single high oral dose of myrcene, the duration of drug-induced sleep was longer; after repeated administration over 14 days, it was shorter. The authors discussed a possible effect on drug metabolism. These observations do not prove a corresponding effect in humans. They do, however, caution against deriving a general sleep formula from a single barbiturate test.
Is there a human study?
There is a clinical sleep study in which myrcene was one of several components. Wang and colleagues randomised 125 adults with insomnia in a double-blind crossover trial. An orally administered capsule containing 300 mg of CBD and 1 mg each of eight terpenes was compared with placebo. In addition to myrcene, the mixture contained substances including linalool, limonene and pinene, but no THC. Complete data from 56 people were available for analysis. This represents a substantial reduction from the number randomised.
The predefined primary endpoint was the combined proportion of deep and REM sleep in total sleep time, recorded using a wristband. In the analysed group, this proportion was, on average, 1.3 percentage points higher with the CBD-terpene mixture than with placebo; the reported 95% confidence interval ranges from 0.1 to 2.5 percentage points. Total sleep time did not change significantly. The result concerns the combination and this measurement approach. Without a comparison arm using “CBD without terpenes” or “myrcene alone”, myrcene’s contribution to the finding cannot be determined.
The authors report additional analyses of small subgroups. Such signals may provide a basis for new studies. They are insufficient to support a statement such as “myrcene-rich flowers reliably help people fall asleep”, partly because neither myrcene alone nor the inhalation of flower was investigated. A wristband also represents a different measurement approach from a full sleep-laboratory examination.
Another small crossover experiment involving 20 adults tested a capsule containing 3 mg of THC, 6 mg of CBN, 10 mg of CBD and 90 mg of a terpene mixture. The terpenes contained in the mixture were not disclosed individually; only their total amount is known. Improvements in individual sleep questionnaires compared with placebo were reported. Because the terpene composition was not specified individually and several active substances were changed simultaneously, this paper can neither confirm nor refute the role of myrcene. Original abstract, PMID 39980821.
What do more recent myrcene experiments say?
A study using vaporized myrcene and linalool in mice examined anxiety-related behaviour and movement. Its route of administration more closely resembled inhalation, but it did not investigate human sleep. The measured differences depended partly on sex and the experimental conditions. An effect in a mouse anxiety test is not evidence of a sleep therapy. Original paper on the mouse experiment.
A controlled human study of an inhaled combination of THC and β-myrcene is registered under NCT05432284. According to the registry status as of 31 July 2026, it has not yet begun recruitment; the planned study start is July 2027. Among other measures, the protocol records self-reported “tiredness/drowsiness” over six hours as a secondary endpoint, as well as driving performance. It therefore does not measure overnight sleep, and no published efficacy finding is available. The registry entry shows that the isolated interaction is still intended to be investigated specifically.
Can a laboratory report identify a strain that makes you tired?
A batch-specific laboratory report can show how much myrcene was measured in the material tested. The unit and reference basis are important: milligrams per gram of sample, percentage of the sample’s mass or percentage within the measured terpenes are different figures. A high proportion of the terpene profile can coincide with a low absolute content.
The next step would be the amount released by the specific device and inhalation pattern, followed by the amount actually absorbed. Neither figure is normally stated in the laboratory report. Other factors include cannabinoid content, other components, individual sensitivity, expectations and circumstances. Someone who became tired after using a particular flower is describing a genuine experience, but has not thereby isolated myrcene as the cause.
Nor does a boiling point turn a display setting into a myrcene switch. Substances can evaporate below their boiling point, while the material temperature and the device’s set temperature may differ. The discussion of boiling points in vaporizers explains why temperature tables cannot provide a reliable plan of effects.
Conclusion: myth or evidence?
For the specific claim that “myrcene in cannabis reliably makes people tired”, the verdict is: not supported by evidence. Animal experiments show interesting pharmacological findings, particularly in connection with a sleeping medication. Human studies using mixtures investigate different questions and do not allow myrcene to be isolated. This does not mean that every conceivable effect of myrcene has been ruled out. It means that the available data do not support a reliable promise that a flower will help with sleep.
Anyone considering medically supervised use for sleep problems should discuss product selection and changes to treatment with the healthcare professional responsible for their care. A terpene label is no substitute for an individual medical assessment. These experiments provide no basis for adding pure terpenes or essential oils to an inhaled product yourself.
Frequently asked questions
Does myrcene make you drowsy?
A reliable drowsiness-inducing effect in humans has not been demonstrated for isolated myrcene in the amounts typically found in cannabis flower. The well-known animal finding concerns drug-induced sleep following the injection of high amounts of the pure substance.
Does a myrcene-rich strain help with sleep?
A high myrcene level is a laboratory measurement, not a clinically tested sleep prognosis. Experiences with a flower may depend on many components and on the individual. The studies discussed so far do not compare myrcene-rich with myrcene-poor flowers in people with sleep problems.
Did the CBD-terpene study confirm myrcene’s effect?
No. It compared a mixture of CBD and eight terpenes with placebo. The observed difference in a sleep-stage endpoint cannot be attributed to any individual terpene; total sleep time did not change significantly.
Is there better evidence for linalool as a sleep terpene?
A frequently cited linalool paper investigated scent and anxiety-related behaviour in mice, not sleep in humans. It is not an appropriate human study for claims about the effects of cannabis flower on sleep. More information is available in the terpene and entourage overview.
Sources and methodology
This text is an evidence-based literature review, not an original systematic review. The linked original papers and the clinical trial registry entry were examined for the key statements through 28 September 2026. Animal experiments, human studies using mixtures, material analyses and personal experiences are treated separately. Studies of cannabinoids alone were not used as evidence for myrcene. A new controlled human finding concerning isolated myrcene would require a reassessment.